I made (continue to make) good money in DUSA. Skin cancer/lesions is definitely a super growth market. Another one I really like is IMX.
They have a "blockbuster" bomb detector in the "Quantum Sniffer" (demo'd on Fox News last week!) and all indications are that the Navy is delighted with the testing they performed. The qs uses a laser and gas chromatograph to"sniff' explosive vapors virtually instantaneously. No swabs or lengthy analysis, just instant detection in a handheld device. They already have a deal with Invision (now part of GE!) and the publicity machine is really beginning to ramp up. Check out next Monday's IBD where they are featured in "where the big money's flowing", At the top of the list with an "A" accumulation rating.
The market potential for the qs is stupendous. At $25,000 apiece this item will be a mandatory piece of equipment for every military unit, police agency, port facility, sports stadium, border crossing, etc. The market is enormous even without the military apps which is in itself is incredibly huge. Plus, the qs can be "tuned" to detect a myriad of narcotics, if so desired. Anyway, you get the idea. The qs is a serious detector of all kinds of contraband and IMX has all the necessary patents and no genuine competition.
Every terror threat and bombing simply reinforces the need for widespread deployment of this device. Remember, the qs is not a theory, it is a real working device that is currently on a "road show" and showing off it's capabilities on a daily basis. Very likely to end up as a part of InVisions airport baggage screeners. Don't take my word for it. Go to yahoo and read the pr's. They will make a believer out of you.
Now, the best part. IMX has a tiny float of only 4.6 mil. Market cap is right at $100 mil. And they have warrants out that are currently priced at $5.09 that will track with the common ($13.64) dollar for dollar. Terrific leverage available with the warrants. Also, IMX is an extremely viable medical equipment company even without the qs and have a number of exciting opportunities in the cancer area. They don't need qs to make a buck. But their CEO has recognized the potential of the qs and is moving heaven and earth to get this lifesaving device into the mainstream and his success is beginning to become very apparent.
The stock began to move Thursday and Friday but the "TASR-like" move is yet to come. I think we stand a good chance of seeing that move begin Monday. |
